Q2 2022

Filed Aug 15, 2022 · 10-Q · 46 days after period end · 0001477932-22-006035

Q2 2022 · 10-Q

Revenue

$16.00K

+1.8% vs Q2 2021

Net Income

-$1.32M

N/M vs Q2 2021

EPS, diluted—

Operating Income-$1,358,356N/M

Operating Cash Flowderived-$351,705N/M

Same quarter

Metric	Q2 2022	Q2 2021	Q2 2020	Q2 2019
Revenue	$16.00K	$15.72K	$33.70K	$65.98K
Net Income	-$1.32M	-$1.06M	-$738.48K	-$2.04M
EPS Diluted	—	-$0.16	-$0.14	-$0.67

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR